Publications by authors named "Τheodora Douvali"
Article Synopsis
- Psoriasis is a chronic condition, and switching treatment options is common for patients who don't respond well to initial therapies, particularly for those with more severe disease.
- Patients who switch biologics may develop anti-drug antibodies, which could reduce the effectiveness of future treatments.
- An observational study of five patients with severe plaque psoriasis showed that after switching from brodalumab to adalimumab and then back to brodalumab, patients experienced a significant return of efficacy, improving both skin and joint symptoms.